JPRN-UMIN000040407已完成未知
Immunological efficacy of Jinhua Qinggan Granule for COVID-19: an open-label, single-arm trial - COVID-19/Jinhua Qinggan Granule
Administration Department, Takanawa Clinic0 个研究点目标入组 18 人开始时间: 2020年5月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 18
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Current infectious, inflammatory, or immune-related diseases
研究者
相似试验
招募中
1 期
Efficacy and immune mechanism of QingfeiTongluo prescriptions intervention on Mycoplasma pneumoniae pneumonia in childreMycoplasma pneumoniae pneumoniaITMCTR1900002750Tianjin Nankai Hospital
尚未招募
4 期
The efficacy and safety of Jingfang Granules in treating air-conditioning diseasesThe Disease of Air ConditioningITMCTR2000003664Zhangjiagang Hospital of Traditional Chinese Medicine
招募中
3 期
Treatment of Upper Respiratory InfectioCondition 1: Acute nasopharyngitis. Condition 2: Acute sinusitis. Condition 3: Acute pharyngitis. Condition 4: Acute tonsillitis. Condition 5: Acute laryngitis and tracheitis. Condition 6: Acute obstructive laryngitis [croup] and epiglottitis. Condition 7: Acute upper respiratory infections of multiple and unspecified sites.Acute nasopharyngitis [common cold]Acute sinusitisAcute laryngitis and tracheitisAcute obstructive laryngitis [croup] and epiglottitisAcute upper respiratory infections of multiple and unspecified sitesAcute tonsillitisAcute pharyngitisIRCT20210913052453N2Asadabad University of Medical Sciences1,000
已完成
不适用
Immunological efficacy of Qing Fei Pai Du Tang for COVID-19JPRN-UMIN000040341Administration Department, Takanawa Clinic18
尚未招募
1 期
Effect of Yinqiao Qingyan Granules in treating the acute bronchitis infected by respiratory syncytial virus in childreITMCTR2000003301Guangdong Secondary Hospital of Traditional Chinese Medicine